Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Fulcrum Therapeutics, Inc. FULC | BlackRock Inc. BLK | 4,032,876 7.500% | -1,542,440 (-27.67%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Adage Capital Management L.P. | 3,000,000 5.560% | 3,000,000 (New Position) | Filing History |
| 2025-01-06 4:50 pm Purchase | 2024-12-27 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,404,612 6.300% | 2,221,821 (+187.85%) | Filing History |
| 2024-12-06 4:28 pm Sale | 2024-11-30 | 13G | Fulcrum Therapeutics, Inc. FULC | BlackRock Inc. BLK | 5,575,316 10.300% | -131,304 (-2.30%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | Nantahala Capital Management, LLC | 4,777,912 7.657% | 4,777,912 (New Position) | Filing History |
| 2024-11-14 4:25 pm Sale | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,182,791 2.200% | -4,336,090 (-78.57%) | Filing History |
| 2024-11-14 06:15 am Sale | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 0 0.000% | -5,469,956 (Position Closed) | Filing History |
| 2024-11-12 3:51 pm Unchanged | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | The Vanguard Group | 3,274,592 5.240% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | BlackRock Inc. BLK | 5,706,620 9.100% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:49 am Purchase | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | The Vanguard Group | 3,274,592 5.240% | 3,274,592 (New Position) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC | BlackRock Inc. BLK | 5,706,620 9.100% | 4,192,195 (+276.82%) | Filing History |
| 2024-10-07 11:37 am Sale | 2024-10-04 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR LLC | 1,724,014 2.762% | -3,960,601 (-69.67%) | Filing History |
| 2024-09-20 4:21 pm Purchase | 2024-09-12 | 13G | Fulcrum Therapeutics, Inc. FULC | TCG Crossover GP II, LLC | 5,000,000 9.400% | 5,000,000 (New Position) | Filing History |
| 2024-09-16 8:21 pm Purchase | 2024-09-12 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 10,229,099 19.300% | 4,684,883 (+84.50%) | Filing History |
| 2024-08-23 4:16 pm Sale | 2024-08-21 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 5,544,216 9.990% | -6,065,488 (-52.24%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 11,609,704 18.800% | 1,923,076 (+19.85%) | Filing History |
| 2024-02-14 4:19 pm Unchanged | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 2,343,154 3.800% | 0 (Unchanged) | Filing History |
| 2024-02-14 07:53 am Purchase | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW INVESTMENTS LP | 5,469,956 8.800% | 476,677 (+9.55%) | Filing History |
| 2024-02-13 12:08 pm Purchase | 2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,518,881 8.900% | 1,244,078 (+29.10%) | Filing History |
| 2024-02-09 09:03 am Purchase | 2024-02-08 | 13G | Fulcrum Therapeutics, Inc. FULC | FMR LLC | 5,684,615 9.195% | 450,890 (+8.62%) | Filing History |